The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 23, 2017
Filed:
Feb. 24, 2014
Applicant:
Cj Cheiljedang Corporation, Seoul, KR;
Inventors:
Assignee:
CJ CHEILJEDANG CORPORATION, Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 35/76 (2015.01); A01N 63/00 (2006.01); A23L 3/3463 (2006.01); A23L 2/44 (2006.01); A23K 10/18 (2016.01); A23K 20/195 (2016.01); A23K 50/30 (2016.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A01N 63/00 (2013.01); A23K 10/18 (2016.05); A23K 20/195 (2016.05); A23K 50/30 (2016.05); A23L 2/44 (2013.01); A23L 3/3463 (2013.01); A61K 35/76 (2013.01); C12N 2795/10221 (2013.01); C12N 2795/10231 (2013.01); C12N 2795/10233 (2013.01);
Abstract
Provided is a novel bacteriophage ΦCJ19 (KCCM11361P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ19 (KCCM11361P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenicin animals except for humans using the bacteriophage ΦCJ19 (KCCM11361P) or the antibacterial composition containing the bacteriophage ΦCJ19 (KCCM11361P) as an active ingredient.